INSP

Inspire Medical Systems, Inc.

About INSP

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of invasive solutions for patients with obstructive sleep apnea (OSA). The obstructive sleep apnea device that treats the root cause of sleep apnea by working inside the body with the patient’s natural breathing process. The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its system to the hospitals and ambulatory surgery centers (ASCs) in the United States and in select countries in Europe through a direct sales organization.

Buy US stocks in Australia starting with INSP. Open an account and start investing today!

Market Capitalisation

$7.32B

Price-earnings ratio

Dividend yield

0.00%

Volume

113.85K

High today

$255.54

Low today

$250.07

Open price

$252.24

52-week high

$272.04

52-week low

$142.74

INSP FAQs

How much is one share of Inspire Medical Systems, Inc.?

One share of Inspire Medical Systems, Inc. is valued at $253.99.

What is the ticker symbol for Inspire Medical Systems, Inc.?

The ticker symbol for Inspire Medical Systems, Inc. is INSP.

How do I buy INSP shares in Australia?

To buy INSP stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in INSP

What is the market capitalisation of Inspire Medical Systems, Inc. INSP?

As of 30/01/2023 Inspire Medical Systems, Inc. has a market cap of $7.3B.

What is the 52-week high for Inspire Medical Systems, Inc. stock?

The Inspire Medical Systems, Inc. 52-week high stock price is $272.04.

What is the 52-week low for Inspire Medical Systems, Inc. stock?

The Inspire Medical Systems, Inc. 52-week low stock price is $142.74.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.